Stay updated on Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check28 days agoChange DetectedThe webpage has been updated to include detailed information about a clinical study evaluating the efficacy and safety of alpelisib plus fulvestrant in treating advanced breast cancer, with specific focus on patient eligibility criteria and treatment protocols. Additionally, several clinical sites and locations have been added or modified.SummaryDifference79%
- Check35 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
Stay in the know with updates to Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.